Speaker Profile
M.D., President, Moonshot Antibodies, Inc
Biography
International leader of surgical oncology. Developed radiotracer guided sentinel node biopsy used worldwide. Led world's largest surgical randomized trial in breast cancer. Founder of 3 companies. Holder of multiple patents. Leader of team developing new category of cancer therapy (this proposal)
Talk
Personalized panels of antibodies to cure cancer
Cancers grow and continue to mutate. Each cancer generates a vast, highly unique set of mutated proteins on the cell surface. Moonshot makes the ultimate personalized medicine, custom antibodies to bind each patients unique mutated proteins. Powerful preclinical results have led to FDA approved Phase 1 trial.
Emerging Therapeutics Showcase:
Moonshot Antibodies, Inc
Moonshot is a new cancer treatment company that has developed the ultimate personalized therapy by making small batch custom antibodies that target the unique signature of cell surface mutated proteins.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 Emerging Therapeutics Showcase will provide a 15-30 minute time slot for selected companies and researchers in the CRISPR, Cell and Gene Therapy fields. Major advancements in safer cell- and gene-level editing technologies are bringing us closer toward cures for life-threatening disorders, from cancer to HIV to Huntington’s disease. Cell therapy, in which cellular material such as T cells capable of fighting cancer cells, is injected into a patient, has been demonstrated safe and effective. The popular new CRISPR tool that has been used to edit the genetic code of nearly any organism will have an enormous impact on human health. More than a dozen clinical trials employing CRISPR on human cells are already underway.
- Emerging Therapeutics/Cell Therapy
- Emerging Therapeutics/CVD
- Emerging Therapeutics/Gene Therapy
- Emerging Therapeutics/Immunotherapy
- Emerging Therapeutics/Radiation Therapy
